WAM
IRWD icon

Wolverine Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Wolverine Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-59,700
Closed -$520K – 1711
2024
Q1 		$520K Buy
+59,700
New +$724K 0.01% 801
2020
Q2 		– Sell
-100
Closed -$1K – 1658
2020
Q1 		$1K Sell
100
-83,200
-100% -$978K ﹤0.01% 1410
2019
Q4 		$1.11M Sell
83,300
-26,200
-24% -$289K 0.01% 596
2019
Q3 		$940K Buy
109,500
+109,100
+27,275% +$1.06M 0.01% 623
2019
Q2 		$4K Buy
+400
New +$4.48K ﹤0.01% 1346
2018
Q4 		– Sell
-51,461
Closed -$795K – 1680
2018
Q3 		$795K Sell
51,461
-306,858
-86% -$4.85M 0.01% 892
2018
Q2 		$5.74M Buy
358,319
+90,027
+34% +$1.33M 0.07% 257
2018
Q1 		$3.47M Buy
268,292
+178,145
+198% +$2.22M 0.04% 352
2017
Q4 		$1.13M Buy
90,147
+47,044
+109% +$614K 0.01% 689
2017
Q3 		$569K Buy
43,103
+9,432
+28% +$130K 0.01% 805
2017
Q2 		$532K Sell
33,671
-48,476
-59% -$704K 0.01% 766
2017
Q1 		$1.17M Sell
82,147
-55,760
-40% -$762K 0.02% 502
2016
Q4 		$1.76M Sell
137,907
-293,485
-68% -$3.71M 0.02% 431
2016
Q3 		$5.74M Sell
431,392
-773,115
-64% -$9.04M 0.09% 216
2016
Q2 		$13.2M Buy
1,204,507
+1,197,701
+17,598% +$11.7M 0.2% 112
2016
Q1 		$348K Buy
6,806
+3,208
+89% +$26.5K 0.01% 582
2015
Q4 		$337K Sell
3,598
-216
-6% -$2.09K 0.01% 742
2015
Q3 		$798K Buy
3,814
+1,553
+69% +$14.5K 0.02% 568
2015
Q2 		$385K Buy
+2,261
New +$26.3K 0.01% 727

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Wolverine Asset Management's IRWD Position: Q2 2024 in Review

Wolverine Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 40,822 shares — an estimated $356K sold.

Wolverine Asset Management first reported a position in IRWD in Q1 2021 and held it in 2 quarters. The position peaked at $356K in Q1 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • Wolverine Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 40,822 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $356K.
  • Wolverine Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 2 quarters.
  • Wolverine Asset Management's Ironwood Pharmaceuticals position peaked at $356K in Q1 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on Wolverine Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.